hyperstimulation syndrome in a sentence

1. Ovarian hyperstimulation syndrome ( OHSS ) occurs in 5-10 % of cases.
2. But ovarian hyperstimulation syndrome may not be so rare.
3. This is a minimally invasive procedure, but it does carry some health risks, such as ovarian hyperstimulation syndrome.
4. Rare adverse events ( < 1 % of people ) include : baldness and / or ovarian hyperstimulation syndrome.
5. Some patients with ovarian hyperstimulation syndrome may have mutations in the gene for FSHR, making them more sensitive to gonadotropin stimulation.
6. It's difficult to find hyperstimulation syndrome in a sentence.
7. On the other hand, the GnRH antagonist protocol has a lower risk of ovarian hyperstimulation syndrome ( OHSS ), which is a life-threatening complication.
8. Findings are conflicting, but metformin treatment as a complement in IVF cycles may reduce the risk of ovarian hyperstimulation syndrome and increase live birth rates.
9. There is no evidence for an increased risk of ovarian hyperstimulation syndrome ( OHSS ) with IVF when compared with ovarian stimulation combined with IUI.
10. Induction of final maturation ( such as done with hCG ) may need to be withheld because of increased risk of ovarian hyperstimulation syndrome ( OHSS ).
11. In cycles followed by oocyte donation, use of GnRH agonists instead of hCG decreases the risk of ovarian hyperstimulation syndrome with no evidence of a difference in live birth rate.
12. In fresh ( rather than " in vitro " fertilization, final oocyte maturation triggering with GnRH agonist instead of hCG decreases the risk of ovarian hyperstimulation syndrome but decreases live birth rate.
13. "Coasting ", which is ovarian hyperstimulation without induction of final maturation, does not significantly decrease the risk of ovarian hyperstimulation syndrome ( OHSS ), according to a Cochrane review of randomized trials.
14. Less common causes include esophageal rupture or pancreatic disease, intra-abdominal abscesses, rheumatoid arthritis, asbestos pleural effusion, mesothelioma, Meigs'syndrome ( ascites and pleural effusion due to a benign ovarian tumor ), and ovarian hyperstimulation syndrome.
15. A small number of underpowered randomized trials came to the result that use of clomifene in addition to gonadotropins results in similar live birth rate but with a reduction in the incidence of ovarian hyperstimulation syndrome.
16. Using a GnRH agonist instead of hCG for inducing final oocyte maturation and / or release results in an elimination of the risk of ovarian hyperstimulation syndrome, but a slight decrease of the delivery rate of approximately 6 %.
More:   1  2